跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATRIZIN SYRUP - HSA Drug Approval Details
Approvals
/
HSA
/
ATRIZIN SYRUP
Approved
THERAPEUTIC
ATRIZIN SYRUP
BEXIMCO PHARMACEUTICALS LTD
🇸🇬 Health Sciences Authority
Approval Date
Mar 22, 2005
Approval ID
3600cb29128f97ba
Company
BEXIMCO PHARMACEUTICALS LTD
Type
Therapeutic
Approval Details
Approval Id
3600cb29128f97ba
Drug Name
ATRIZIN SYRUP
Product Name
ATRIZIN SYRUP
Approval Number
SIN13068P
Approval Date
2005-03-22
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R06AE07
Atc Item Name
cetirizine
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
CETIRIZINE HYDROCHLORIDE
0.060 g
CETIRIZINE HYDROCHLORIDE
0.060 g
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 22, 2005
Approval ID
3600cb29128f97ba
Type
Therapeutic
Back to HSA Approvals